3-Chloro-2-(3-cyclobutoxy-4-difluoromethoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one → 3-Chloro-2-(3-cyclopropylmethoxy-4-methoxyphenyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one
반응식
[Cl:1][C:2]1[C:10]2[C:9](=[O:11])[NH:8][N:7]=[CH:6][C:5]=2[N:4](COCC[Si](C)(C)C)[C:3]=1[C:20]1[CH:25]=[CH:24][C:23]([O:26][CH3:27])=[C:22]([O:28][CH2:29][CH:30]2[CH2:32][CH2:31]2)[CH:21]=1.ClC1C2C(=O)NN=CC=2N(COCC[Si](C)(C)C)C=1C1C=CC(OC(F)F)=C(OC2CCC2)C=1>>[Cl:1][C:2]1[C:10]2[C:9](=[O:11])[NH:8][N:7]=[CH:6][C:5]=2[NH:4][C:3]=1[C:20]1[CH:25]=[CH:24][C:23]([O:26][CH3:27])=[C:22]([O:28][CH2:29][CH:30]2[CH2:32][CH2:31]2)[CH:21]=1참가 물질
3
반응물 2
생성물 1
실험 절차
Reaction and post treatment were carried out in the same manner as in Example 32-(b) except for using 340 mg (0.71 mmol) of 3-chloro-2-(3-cyclopropylmethoxy-4-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one obtained in Example 47-(a) in place of 3-chloro-2-(3-cyclobutoxy-4-difluoromethoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one, whereby 134 mg of the title compound was obtained as a white solid. (Yield: 55%)